S Y Tse
Chief Executive Officer chez SINO BIOPHARMACEUTICAL LIMITED
Fortune : 1 565 M $ au 31/03/2024
Profil
S Y Tse est membre du conseil d'administration de Sino Biopharmaceutical Ltd. S Y Tse a obtenu un diplôme de premier cycle à la Wharton School de l'université de Pennsylvanie et un diplôme d'études supérieures au Schwarzman College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/04/2024 | 4 055 000 000 ( 21,57% ) | 1 565 M $ | 31/03/2024 |
Postes actifs de S Y Tse
| Sociétés | Poste | Début |
|---|---|---|
| SINO BIOPHARMACEUTICAL LIMITED | Chief Executive Officer | 28/07/2022 |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
 Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Director/Board Member | 10/11/2020 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Chairman | 30/07/2020 |
Anciens postes connus de S Y Tse
| Sociétés | Poste | Fin |
|---|---|---|
| Liepin North America, Inc. | Chief Executive Officer | - |
Formation de S Y Tse
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| Schwarzman College | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd.
Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Quanyuantang Pharmacy Chain Joint Stock Co., Ltd. is an omni-channel smart retail pharmacy. It operates both offline and online retail pharmacies. It sells and delivers pharmaceutical products through its O2O and B2C platforms. It is also involved in the wholesale of pharmaceutical products to other industry customers. The company was founded by Can Li and Zhou Hua Chen on September 12, 2012 and is headquartered in Chengdu, China. | Health Technology |
| Liepin North America, Inc. |
